Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Pediatrics

Selective CT for PET/CT dose reduction in Langerhans cell histiocytosis

Michael Gelfand, Susan Sharp and Joseph Palumbo
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1401;
Michael Gelfand
1Radiology, Cincinnati Children's Hospital, Cincinnati, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Sharp
1Radiology, Cincinnati Children's Hospital, Cincinnati, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Palumbo
2Hematology/Oncology, Cincinnati Children's Hospital, Cincinnati, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1401

Objectives In Langerhans cell histiocytosis (LCH), FDG PET demonstrates active disease in bone, while x-ray, bone scan, MRI and CT show effects of bone destruction. We describe a selective CT method for reducing effective dose (ED) from FDG PET/CT in LCH, using whole body attenuation correction (AC) only CT with selective regional CT at localization (loc) settings.

Methods 51 PET/CT scans were performed in 23 LCH patients (pt). Median pt age was 8.5 yrs (range 1-25 yrs). 17 scans were performed with loc CT settings. 34 were performed with AC only CT settings; bed positions were repeated at loc CT settings in regions with abnormal PET findings.

Results Of 34 AC only PET/CT scans, 10 required repeat loc CT of limited body regions (non-head), with 1-3 bed positions re-scanned for each region (total 17 bed positions). The head was re-scanned with loc CT 18 times, but further analysis indicated that, with minor changes in AC only CT settings, lytic bone lesions were easily recognized at modified AC only settings. Calculated average ED for AC only PET/CT scans at modified settings was 0.60 mSv. Average ED for the 10 repeat regional body CT scans at loc settings was 1.16 mSv. Average total ED for all 34 scans performed at AC CT settings (including the 10 loc CT body re-scans) was 0.94 mSv. High quality PET scans were consistently obtained with FDG activities of 0.10 mCi/kg; average total ED for FDG+CT for the 34 scans was 5.45 mSv. For routine FDG+CT using a typical 0.14 mCi/kg FDG dose and whole body loc CT, average ED for the 34 scans is calculated to be 12.2 mSv. Use of the selective CT method reduced ED from CT by 70%; reduction in total FDG+CT ED was 55% for selective CT and a 0.1 mCi/kg FDG dose. PET was abnormal in 25/51 scans in 12/23 pt. In active LCH, abnormal FDG uptake was seen in all lytic bone lesions >1cm, including the skull. FDG uptake in skull lesions <1cm was inconsistently detected.

Conclusions Significant reductions in ED can be achieved with use of selective CT techniques for FDG PET/CT imaging in LCH

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Selective CT for PET/CT dose reduction in Langerhans cell histiocytosis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Selective CT for PET/CT dose reduction in Langerhans cell histiocytosis
Michael Gelfand, Susan Sharp, Joseph Palumbo
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1401;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Selective CT for PET/CT dose reduction in Langerhans cell histiocytosis
Michael Gelfand, Susan Sharp, Joseph Palumbo
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1401;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Pediatrics

  • Simplified weight-based, low dose pediatric F18-FDG PET/CT protocols: Dosimetry
  • A dataset of normal cerebral FDG PET/CT in children: Opening the door to statistical parametric mapping
  • In pediatric Hodgkin's disease, diffuse marrow uptake on staging FDG-PET correlates with B symptoms
Show more General Clinical Specialties: Pediatrics

Pediatrics Posters

  • Estimate Split Renal Function Using 99mTc-DMSA SPECT/CT in Infants with Antenatally Detected Hydronephrosis
  • Incremental value of 18F-FDG PET/CT over conventional imaging in the initial staging of pediatric Ewing sarcoma
  • Use of optimized post-contrast enhanced PET/CT to improve diagnostic accuracy, staging, and follow-up of children with cancer
Show more Pediatrics Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire